MedPath

Effect of Ganoderma lucidum in improving Psoriasis symptoms

Phase 2
Recruiting
Conditions
Psoriasis.
Psoriasis
Registration Number
IRCT20160306026938N7
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
15
Inclusion Criteria

male or female volunteers with mild to moderate psoriasis
patients between 19 and 59 years old
healthy physical condition
informed signature on consent form

Exclusion Criteria

having any systemic disease that affects the skin
using any topical or oral product to treat psoriasis in the last 4 weeks
using moisturizers during the study
using and cotacting with any chemicals such as solvents during the study without informing the researchers
people with cancer
pregnant and lactating women

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The level of burning and itching. Timepoint: 2 and 4 weeks after receiving the medicine. Method of measurement: Asking the patient and psi score.
Secondary Outcome Measures
NameTimeMethod
PSI score. Timepoint: At the begining of the intervention and then, 2 and 4 weeks after receiving the medicine. Method of measurement: ???? ?????? ????? ???? ? ???? ????.
© Copyright 2025. All Rights Reserved by MedPath